Connect with us

Technology

Transforming Healthcare with AI: YiduTech’s Gong Rujing at Summer Davos

Published

on

DALIAN, China, June 30, 2024 /PRNewswire/ — “AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry.” At the 15th Annual Meeting of the New Champions, also known as Summer Davos, in Dalian, Ms. Gong Rujing (Yingying), Chairwoman and Founder of Yidu Tech, was invited as a distinguished representative of the healthcare technology sector. She shared her unique insights into the future of AI in healthcare during the thematic dialogue on “Healthcare Analytics, Not Moving Fast Enough.”

This year marks the 10th anniversary of Yidu Tech and Ms. Gong Rujing’s decade-long dedication to the healthcare industry. “I will continue this mission for decades to come and strive to do even better,” she stated. From the inception of her entrepreneurial journey 10 years ago, she has been driven by the mission to leverage the power of technology to deliver precise healthcare to every individual.

Ms. Gong described the past decade as a journey filled with miracles and achievements. During this period, Yidu Tech has progressively established close collaborations with key stakeholders in the healthcare industry, including government agencies, hospitals, pharmaceutical companies, insurance firms, experts, and clinicians. As of March 31, 2024, Yidu Tech’s “AI Medical Brain” YiduCore has been authorized to process and analyze over 5 billion medical records, covering more than 2,500 hospitals. Leveraging YiduCore’s accumulated understanding of AI technology and medical knowledge, Yidu Tech and its partners are jointly driving innovation and progress in the healthcare field.

In regional population health management, Yidu Tech has assisted in constructing urban “health brains,” with several benchmark projects implemented in cities such as Beijing and Ningbo. In AI-powered clinical research, Yidu Tech has supported researchers and clinicians in producing over 240 high-level papers, accelerating the application of research outcomes. Additionally, Yidu Tech provides clinical trial services to globally renowned pharmaceutical companies, helping them optimize trial processes, reduce costs, and bring new drugs to market more swiftly, ultimately benefiting patients. In healthcare management, Yidu Tech’s AI technology plays a crucial role by analyzing vast amounts of medical data to provide comprehensive decision support to healthcare administrators, helping them optimize resource allocation and improve service efficiency. The number of active users on Yidu Tech’s health management platform, each completing at least one transaction, has reached nearly 27.6 million. “These achievements are all empowered by medical data analysis and AI technology.”

“We are now entering a new era of AI technology.” The development of large language model technologies has opened up new possibilities across various industries. Yidu Tech has independently developed a large model specific to the medical field and is advancing its application across the entire healthcare industry chain, including medicine, pharmaceuticals, insurance, and patients. The goal is to promote further progress and innovation through new AI technologies. However, Ms. Gong also emphasized that the healthcare industry is professional, complex, and sensitive, and the application of new technologies must address challenges such as data security, privacy protection, and ethics.

“Data security and privacy protection are fundamental to the development of AI technology and medical big data technology. We must ensure that all stakeholders are satisfied with compliance, security, accessibility, and privacy protection.” She illustrated this point with a vivid example: “If a patient is in a coma and in critical condition, unable to express their wishes, should the doctor immediately access their medical records without the patient’s consent? This requires deep consideration and balance.”

“AI technology still has a long way to go.” She called on policymakers, healthcare institutions, and technology companies to work together to realize the immense potential of healthcare data. Ms. Gong highlighted that building trust is key, and enhancing data operability is essential to fully unleash the power of data. “It’s not just about better data quality; it’s about a better future for health.”

Joining Ms. Gong in the dialogue were Professor Chong Yap Seng, Dean of the Yong Loo Lin School of Medicine at the National University of Singapore; Dr. Brandon Suh, CEO of Lunit; and Dr. Angela Wang Nan, Senior Vice President and Chief Investment Officer of Neusoft Group, and Chairman and President of Neusoft Europe.

View original content:https://www.prnewswire.com/news-releases/transforming-healthcare-with-ai-yidutechs-gong-rujing-at-summer-davos-302186524.html

SOURCE Yidu Tech

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

ZINZINO AB (PUBL.): ENTERS INTO AGREEMENT TO PROVIDE DIP FINANCING TO ZURVITA INITIATING CHAPTER 11 PROCESS

Published

on

By

GOTHENBURG, Sweden, Dec. 22, 2024 /PRNewswire/ — Zinzino has in a press release dated 20240617 announced that a letter of intent to acquire 100% of the shares in the North American direct selling company Zurvita Inc. “Zurvita or the Company” was signed. Since then, Zinzino has negotiated with the owners of Zurvita Inc. and instead concluded that the purchase of Zurvita’s assets in a Chapter 11 proceeding for the Company is in Zinzino’s best interest.

Zinzino is providing a debtor-in-possession (DIP) financing to Zurvita, which filed for Chapter 11 bankruptcy proceedings on the 20th December 2024. By entering as a financier in Zurvita’s Chapter 11 with loans totaling USD 4.5 million, Zinzino simultaneously makes an offer to acquire the company’s assets via a so-called stalking horse bid. If the bid is accepted, the DIP loan will be converted into part of a debt-settled purchase price, which will be determined after Zurvita has completed the sale process that is subject to higher and better offers in accordance with the applicable terms of Chapter 11. Other bidders have the right to submit bids for Zurvita during the process and if another bid is accepted, Zinzino’s loan will be repaid and certain of its costs associated with the process will be reimbursed. 

Zurvita is a direct selling health company with operations in the United States, Canada and Mexico. The brand portfolio offers a range of innovative health and wellness products. The business has total annual sales of approximately USD 30 million with good gross margins. A potential transaction with Zinzino is expected to add growth through the synergies arising from the joint networks, combined with Zinzino’s test-based product concept. The profitability of the Company will thus be able to develop well by utilizing Zinzino’s existing technical platform and organization.

A visionary mindset, tech first perspective, test-based nutrition at the cellular level and a strong position to capitalize on current trends will form the basis of the new partnership. Following the acquisitions of VMA Life in 2020, Enhanzz in 2022, the strategic partnership with ACN and the recently completed asset acquisition of Xelliss, Zinzino has been looking for further strong investments to maintain its sustainable, profitable growth, strengthen its distribution power, expand into new markets and leverage the product portfolio in new consumer areas.

– “Individualized advice and tailored solutions are the future, and not just in health and wellness,” says Dag Bergheim Pettersen, CEO of Zinzino. “Together, we have years of combined industry experience and everything it takes to drive the modern, personalized shopping experience through direct sales”. Jay Shafer, CEO and co-founder of Zurvita, states “After considering multiple options for the company and under the guidance of our attorneys and third-party advisors, we feel this presents the best opportunity to continue Zurvita’s mission, deliver the highest quality products, and provide continuity for our staff and consultants. We are excited to see what the future holds for Zurvita.” 

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, www.zinzino.com

Pictures for publication free of charge:
marketing@zinzino.com

Certified Adviser:
Carnegie Investment Bank AB (publ.)

Zinzino AB (publ.) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 20.00 on the 21st of December 2024.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/zinzino-ab–publ–enters-into-agreement-to-provide-dip-financing-to-zurvita-initiating-chapter-11-pr,c4086040

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-enters-into-agreement-to-provide-dip-financing-to-zurvita-initiating-chapter-11-process-302337945.html

Continue Reading

Technology

Meet With Culture: Exquisite Craftsmanship of Traditional Chinese Architecture

Published

on

By

BEIJING, Dec. 22, 2024 /PRNewswire/ — The Temple of Agriculture in Beijing played a significant role during the Ming (1368-1644) and Qing (1644-1911) dynasties. Over nearly 600 years, 25 emperors personally visited or sent ministers to perform spring farming ceremonies and offer sacrifices to Shennong, the god of agriculture.

 

Built in 1420 during the Yongle reign, the temple’s predecessor was the Temple of Mountains and Rivers in Nanjing. When Emperor Zhu Di moved the Ming capital to Beijing, he constructed a larger temple inspired by the Nanjing temple, which gradually evolved into the Temple of Agriculture.

The Taisui Hall, the largest building complex in the temple, now serves as a major exhibition hall of the Beijing Ancient Architecture Museum, showcasing models of classical Chinese buildings and demonstrating the solemnity of royal architecture.

Ancient Chinese architecture is predominantly wooden-structured, chosen for its availability, versatility, and earthquake resistance. Artisans developed sophisticated techniques in material selection and construction. The wooden framework consists of columns, beams, girders, and purlins, with innovative structural forms like lifting-beam and piercing-bracket structures.

A unique architectural element is the dougong (bracket sets), which supports weight and connects beam frames with column walls. Mortise-tenon joints were invented to create elastic frameworks by connecting different components.

While discussing the Temple of Agriculture, it’s worth noting another remarkable example of architectural hierarchy which could be found in the Temple of Heaven. The hierarchy of architectural designs reflected social stratification, with eave structures like the triple-layered eaves of the Hall of Prayer for Good Harvest representing the highest-level architectural design.

Over centuries, the Temple of Agriculture has transformed from an imperial garden to a public park and a museum for historical architecture, now standing as a significant cultural landmark that symbolizes China’s agricultural civilization and architectural heritage along Beijing’s Central Axis.

Quickly join Alexandre to study and explore the traditional Chinese architecture.
https://youtu.be/YpA03WiZ9Wc

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/meet-with-culture-exquisite-craftsmanship-of-traditional-chinese-architecture-302337935.html

SOURCE China International Communications Group

Continue Reading

Technology

Second Opinion Expert Announces Filing of U.S. Patent for Method of Generating Medical Opinions Using Artificial Intelligence

Published

on

By

Patent leverages AI technology to improve patient outcomes and reduce cost of care

DANA POINT, Calif., Dec. 22, 2024 /PRNewswire-PRWeb/ — SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that it has filed patent application 133902-0002UT01 with the United States Patent and Trademark Office entitled “Method and Apparatus for Generating Automated Medical Opinions Using Artificial Intelligence.” The patent covers the company’s proprietary system that communicates a medical opinion to a user based on a trained model that uses artificial intelligence (AI) or machine learning (ML).

“In the near future, we’ll launch our free app, enabling users to access high-quality medical opinions. This innovative app empowers individuals with insightful medical guidance that improves health and saves lives,” said Steve Krause, President of SecondOpinionExpert, Inc.”

Medical second opinions have traditionally been obtained by seeking out another healthcare professional who reviews the patient’s medical records, diagnoses, and tests. However, the rapidly increasing complexity of medical information, the demand for faster turnaround times, and the limitations of human expert availability have created a need for automated systems that utilize AI to generate both first and second medical opinions.

Artificial intelligence has made significant strides in medical diagnostics, including image recognition, predictive modeling, and natural language processing (NLP). These advancements present an opportunity to augment traditional second opinion systems by automatically processing patient medical records, diagnostic tests, and clinical data to generate high-quality first and second medical opinions.

SecondOpinionExpert’s technology increases the quality and efficiency of healthcare delivery, improves healthcare access and empowers doctors and patients to make better informed medical decisions. The HIPAA-compliant patented platform leverages recent advancements in artificial intelligence, machine learning and electronic medical record systems enabling the company to provide fast, reliable and secure online medical opinions. The system provides patients greater peace of mind by leveraging the power of AI and ML.

“Our patent-pending AI enabled technology platform provides a cost-effective choice that improves patient care,” said Steve Krause, President, SecondOpinionExpert, Inc. “In the near future, we look forward to launching our user-friendly app that will be initially free of charge. People using our platform will be able to quickly obtain high quality medical opinions while avoiding unnecessary travel time and expense, knowing that they will be getting insightful medical guidance that improves health and saves lives.”

About SecondOpinionExpert

SOE’s mission is to provide innovative medical technology solutions to improve healthcare while reducing costs.

Our patented HIPAA-compliant platform leverages recent advancements in artificial intelligence, machine learning and electronic medical record systems, enabling the company to provide fast, reliable and secure online medical opinions to inform both diagnosis and treatment planning. We empower patients, providers and payors to work together to make the best possible medical decisions, leading to better health outcomes and greater peace of mind for patients. SOE’s panel of 400+ board-certified medical specialists are available to render expert opinions informed as needed by AI and genomics.

SOE also owns and/or manages a rapidly growing network of facilities for post-acute care and substance treatment. Our proprietary platform for Electronic Medical Records (EMR) empowers best practices in administration and medical services.

Our proprietary TeleMedics Mobile Platform empowers and chronicles on-site visits from qualified medics or nurses. Mobile staff provide the human connection, capturing vitals and doing diagnostics and therapeutics, with the patient’s doctor participating as needed through live video. We work with our affiliate Intra Care, Inc. to provide superior home health and hospice care. We provide Remote Patient Monitoring (RPM) delivered through a strategic relationship with KangarooHealth, in-home respirators delivered and monitored by SOE affiliate Momentum Equipment and Pandemic Response through our MaxVax solution.

Additional information can be found at SOE.CARE

Media Contact

Jay Kilberg, Second Opinion Expert, Inc., 1 917.543.6285, jay.kilberg@soe.care, https://soe.care

Facebook, LinkedIn

View original content to download multimedia:https://www.prweb.com/releases/second-opinion-expert-announces-filing-of-us-patent-for-method-of-generating-medical-opinions-using-artificial-intelligence-302337240.html

SOURCE Second Opinion Expert, Inc.

Continue Reading

Trending